OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VICP57

Vicplas International Ltd

Medical Equipment, Supplies & DistributionVerified

Vicplas International Ltd exhibits a capital structure with a debt-to-equity ratio of 0.58, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.46, suggesting it can cover its short-term obligations with its current assets. However, the company's cash and equivalents amount to SGD 4.714 million, which is significantly lower than its long-term debt of SGD 41.112 million, resulting in a negative net cash position. Profitability metrics reveal a challenging financial performance, with a return on equity (ROE) of -3.3% and a return on assets (ROA) of -1.71%. These figures indicate that the company is not generating returns that exceed its cost of capital, which is a concern for investors. The operating income of SGD 93,000 is minimal compared to the company's revenue of SGD 115.768 million, highlighting inefficiencies in cost management or pricing strategies. The company's revenue is distributed across two segments: Medical devices and Pipes & pipe fittings. The medical devices segment is a key contributor to the company's operations, with subsidiaries in Singapore, China, and the United Kingdom. The pipes & pipe fittings segment serves a diverse range of industries, including water systems and underground electrical systems. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the performance of each business line. The company's growth trajectory is uncertain, as the financial data does not provide forward-looking guidance or historical revenue growth rates. The negative net income of SGD 2.357 million and the free cash flow of SGD -1.036 million suggest that the company is not generating sufficient cash to sustain operations or fund growth initiatives. The capital expenditure of SGD -6.421 million indicates that the company is investing in its operations, but the negative value suggests that the investments are not yet yielding positive returns. The risk assessment highlights a medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. The dilution risk is classified as low, indicating that the company is not expected to issue additional shares in the near term. The key financial flags include the negative net cash position, which could impact the company's ability to meet its long-term obligations. Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes. The financial data does not include recent transcripts or filings that could provide insights into the company's future plans or challenges. The lack of detailed information on recent events makes it difficult to assess the company's response to market conditions or industry trends.

30-day price · VICP-0.00 (-4.5%)
Low$0.08High$0.09Close$0.09As of17 May, 00:00 UTC
Profile
CompanyVicplas International Ltd
TickerVICP.SI
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Vicplas International Ltd is a Singapore-based holding company that operates in the medical devices and pipes & pipe fittings industries, generating revenue through the manufacturing and distribution of medical devices and piping systems for residential, commercial, and industrial applications.

Classification. Vicplas is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Vicplas International Ltd exhibits a capital structure with a debt-to-equity ratio of 0.58, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.46, suggesting it can cover its short-term obligations with its current assets. However, the company's cash and equivalents amount to SGD 4.714 million, which is significantly lower than its long-term debt of SGD 41.112 million, resulting in a negative net cash position. Profitability metrics reveal a challenging financial performance, with a return on equity (ROE) of -3.3% and a return on assets (ROA) of -1.71%. These figures indicate that the company is not generating returns that exceed its cost of capital, which is a concern for investors. The operating income of SGD 93,000 is minimal compared to the company's revenue of SGD 115.768 million, highlighting inefficiencies in cost management or pricing strategies. The company's revenue is distributed across two segments: Medical devices and Pipes & pipe fittings. The medical devices segment is a key contributor to the company's operations, with subsidiaries in Singapore, China, and the United Kingdom. The pipes & pipe fittings segment serves a diverse range of industries, including water systems and underground electrical systems. However, the financial data does not provide a breakdown of revenue by segment, making it difficult to assess the performance of each business line. The company's growth trajectory is uncertain, as the financial data does not provide forward-looking guidance or historical revenue growth rates. The negative net income of SGD 2.357 million and the free cash flow of SGD -1.036 million suggest that the company is not generating sufficient cash to sustain operations or fund growth initiatives. The capital expenditure of SGD -6.421 million indicates that the company is investing in its operations, but the negative value suggests that the investments are not yet yielding positive returns. The risk assessment highlights a medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. The dilution risk is classified as low, indicating that the company is not expected to issue additional shares in the near term. The key financial flags include the negative net cash position, which could impact the company's ability to meet its long-term obligations. Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes. The financial data does not include recent transcripts or filings that could provide insights into the company's future plans or challenges. The lack of detailed information on recent events makes it difficult to assess the company's response to market conditions or industry trends.
Key takeaways
  • Vicplas International Ltd is operating with a negative net cash position, which could impact its liquidity and ability to meet long-term obligations.
  • The company's profitability metrics, including ROE and ROA, are negative, indicating a lack of returns on equity and assets.
  • The capital structure shows a moderate reliance on debt, with a debt-to-equity ratio of 0.58.
  • The company's growth trajectory is uncertain, with negative net income and free cash flow.
  • The risk assessment indicates a medium liquidity risk and a low dilution risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySGD
Revenue$115.8M
Gross profit$61.5M
Operating income$93.0k
Net income-$2.4M
R&D
SG&A
D&A
SBC
Operating cash flow$388.0k
CapEx-$6.4M
Free cash flow-$1.0M
Total assets$137.7M
Total liabilities$66.3M
Total equity$71.4M
Cash & equivalents$4.7M
Long-term debt$41.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$71.4M
Net cash-$36.4M
Current ratio1.5
Debt/Equity0.6
ROA-1.7%
ROE-3.3%
Cash conversion-16.0%
CapEx/Revenue-5.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricVICPActivity
Op margin0.1%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-2.0%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin53.1%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-5.5%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity58.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 20:06 UTC#b405d5be
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 13:00 UTCJob: 21adafbe